Compare Johnson & Johnson (JNJ) vs Nokia Corp (NOK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Nokia Corp — how do they compare? Johnson & Johnson trades at $260.51 (market cap $626.09B), while Nokia Corp trades at $10.35 (market cap $53.00B). The key difference: Johnson & Johnson is far larger — about 11.8× Nokia Corp's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| JNJ | NOK | |
|---|---|---|
Market Cap | $626.09B | $53.00B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $16.83 |
52-Week Low | $172.78 | $4.13 |
Enterprise Value | $654.37B | $50.95B |
Dividend Yield | 2.06% | 1.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Nokia (NOK) trades at $10.315, up 13.1% on the day, reflecting positive momentum. The stock shows mixed technical signals with a bearish overall trend but neutral oscillators. Fundamentally, revenue was $19.89B in 2025 with a net income margin of 3.47%, while the P/E ratio of 68.07 suggests a premium valuation. Recent earnings have been mixed, with a beat in Q2 2026 but a miss in Q1 2026. News highlights focus on AI infrastructure growth driving demand.
The outlook is cautiously optimistic, supported by strong analyst buy consensus (59.61%) and AI-driven demand tailwinds. However, risks include competitive pressures in telecom, volatility in cash flows, and the high P/E ratio indicating stretched valuations. Investment appeal hinges on successful execution in AI and cloud segments offsetting traditional market challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →
